Prescription digitiser Doxper raises Rs 7.2 crore from Vidal Health, others


Healthtech startup Doxper has raised Rs 7.2 crore from its existing investors Vidal Health and others in a bridge round. The other investors participated in the round include GrowX Ventures, Capier Investments, and Globevestor, among others.

Last year in August, Doxper raised Rs 4.8 crore from Vidal Healthcare and GrowX Ventures in a seed fund round. The company has raised a total of Rs 12 crore since its inception in 2015.

Doxper was founded by three IITians – Randeep Singh, Pawan Jain, and Shailesh Prithani to provide solutions for instant digitisation and archival of prescriptions. It means that doctors can digitise and archive records by using encoded pen and paper system.

Besides doctors, patients can use the Doxper app to access their health records, book appointments, and share reports with doctors. Hospitals can also use the platform to digitise their records by integrating the app-based system.

The platform is actively serving doctors in Delhi-NCR, Jaipur, Mumbai, Pune, and Bengaluru, among others.

The company provides monthly as well as annual subscription packs ranging from Rs 1,250 to 15,000.

It claims to have a presence of around 300 doctors on its platform. The company also plans to work with major hospitals like AIIMS breast cancer clinic, Prashanti Cancer Care, Biocon Foundation and Jain Fertility, among others.

Home healthcare services are growing at a decent pace with other segments of the healthtech space (especially, pathology collection and prescription-based medicine delivery among others).

Also Read: Health-tech startup Doxper receives seed funding from GrowX, others

The Indian healthcare sector is valued at over Rs 7 trillion and is growing at a rate of over 15 per cent per annum making it one of the most attractive sectors for investments.

New age models in healthcare space are poised to disrupt the traditional forms of healthcare delivery and products including digitisation of services and product innovations. Doxper competes with several platforms including Tencent-backed Practo, Lybrate amongst others.

The funding news was first reported by

About Author

Send Suggestions or Tips